Emma Motrico1, Rena Bina2, Sara Domínguez-Salas3, Vera Mateus4, Yolanda Contreras-García5, Mercedes Carrasco-Portiño5, Erilda Ajaz6, Gisele Apter7, Andri Christoforou8, Pelin Dikmen-Yildiz9, Ethel Felice10, Camellia Hancheva11, Eleni Vousoura12, Claire A Wilson13, Rachel Buhagiar10, Carmen Cadarso-Suárez14, Raquel Costa15,16, Emmanuel Devouche17, Ana Ganho-Ávila18, Diego Gómez-Baya19, Francisco Gude20, Eleni Hadjigeorgiou21, Drorit Levy2, Ana Osorio4, María Fe Rodriguez22, Sandra Saldivia23, María Fernanda González24, Marina Mattioli25, Ana Mesquita26. 1. Psychology Department, Universidad Loyola Andalucia, Avenida de las Universidades s/n, Dos Hermanas (Sevilla), Spain. emotrico@uloyola.es. 2. School of Social Work, Bar Ilan University, Ramat Gan, Israel. 3. Psychology Department, Universidad Loyola Andalucia, Avenida de las Universidades s/n, Dos Hermanas (Sevilla), Spain. 4. Graduate Program on Developmental Disorders, Center for Biological and Health Sciences - Mackenzie Presbyterian University, São Paulo, Brazil. 5. Departamento de Obstetricia y Puericultura, Facultad de Medicina, Universidad de Concepción, Concepción, Chile. 6. Department of Education Sciences and Psychology, Beder College University, Tirana, Albania. 7. Perinatal and Child Psychiatry, Le Havre Hospital, Normandie University Rouen, Rouen, France. 8. Department of Social and Behavioral Sciences, European University Cyprus, Nicosia, Cyprus. 9. Department of Psychology, Kirklareli University, Kirklareli, Turkey. 10. University of Malta, Msida, MSD, 2080, Malta. 11. Sofia University "St. Kliment Ochridski", Sofia, Bulgaria. 12. Department of Psychology, American College of Greece, Gravias 6, 15342, Agia Paraskevi, Greece. 13. Section of Women's Mental Health, King's College London and South London and Maudsley NHS Foundation Trust, London, United Kingdom. 14. Department of Statistics, Mathematical Analysis and Optimization, Group of Biostatistics and Biomedical Data Science, Faculty of Medicine, University of Santiago de Compostela, Rúa San Francisco, S/N, 15895, Santiago de Compostela, Spain. 15. Unidade de Investigação em Epidemiologia (EPIUnit, UIDB/04750/2020), Instituto de Saúde Pública da Universidade do Porto (ISPUP). Rua das Taipas, 135, 4050-600, Porto, Portugal. 16. Universidade Europeia, Lisbon, Portugal. 17. Université de Paris, Laboratoire de Psychopathologie et Processus de Santé (LPPS, UR4057), Groupe Hospitalier du Havre, Paris, France. 18. Univ Coimbra, Center for Research in Neuropsychology and Cognitive Behavioral Intervention, Faculty of Psychology and Educational Sciences, 3000-115, Coimbra, Portugal. 19. Department of Social, Developmental and Educational Psychology, Universidad de Huelva, Avda. de las Fuerzas Armadas, 21007, Huelva, Spain. 20. Department of Epidemiology, University Clinical Hospital of Santiago, Research Group on Epidemiology of Common Diseases, Santiago de Compostela Health Research Institute (IDIS), Santiago de Compostela, Spain. 21. Department of Nursing, Midwifery, School of Health Science, Cyprus University of Technology, Limassol, Cyprus. 22. Faculty of Psychology, Universidad Nacional de Educación a Distancia, (UNED), Madrid, Spain. 23. Departamento de Psiquiatría y Salud Mental, Facultad de Medicina, Universidad de Concepción, Concepción, Chile. 24. Faculty of Health Sciences, National University of Entre Rios, Concepción del Uruguay, Entre Ríos, Argentina. 25. Faculty of Humanities, Arts and Social Sciences, Universidad Autónoma de Entre Ríos, Concepción del Uruguay, Entre Ríos, Argentina. 26. School of Psychology, University of Minho, Campus Gualtar, 4710-057, Braga, Portugal. ana.mesquita@psi.uminho.pt.
Abstract
BACKGROUND: Corona Virus Disease 19 (COVID-19) is a new pandemic, declared a public health emergency by the World Health Organization, which could have negative consequences for pregnant and postpartum women. The scarce evidence published to date suggests that perinatal mental health has deteriorated since the COVID-19 outbreak. However, the few studies published so far have some limitations, such as a cross-sectional design and the omission of important factors for the understanding of perinatal mental health, including governmental restriction measures and healthcare practices implemented at the maternity hospitals. Within the Riseup-PPD COST Action, a study is underway to assess the impact of COVID-19 in perinatal mental health. The primary objectives are to (1) evaluate changes in perinatal mental health outcomes; and (2) determine the risk and protective factors for perinatal mental health during the COVID-19 pandemic. Additionally, we will compare the results between the countries participating in the study. METHODS: This is an international prospective cohort study, with a baseline and three follow-up assessments over a six-month period. It is being carried out in 11 European countries (Albania, Bulgaria, Cyprus, France, Greece, Israel, Malta, Portugal, Spain, Turkey, and the United Kingdom), Argentina, Brazil and Chile. The sample consists of adult pregnant and postpartum women (with infants up to 6 months of age). The assessment includes measures on COVID-19 epidemiology and public health measures (Oxford COVID-19 Government Response Tracker dataset), Coronavirus Perinatal Experiences (COPE questionnaires), psychological distress (BSI-18), depression (EPDS), anxiety (GAD-7) and post-traumatic stress symptoms (PTSD checklist for DSM-V). DISCUSSION: This study will provide important information for understanding the impact of the COVID-19 pandemic on perinatal mental health and well-being, including the identification of potential risk and protective factors by implementing predictive models using machine learning techniques. The findings will help policymakers develop suitable guidelines and prevention strategies for perinatal mental health and contribute to designing tailored mental health interventions. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04595123 .
BACKGROUND:Corona Virus Disease 19 (COVID-19) is a new pandemic, declared a public health emergency by the World Health Organization, which could have negative consequences for pregnant and postpartum women. The scarce evidence published to date suggests that perinatal mental health has deteriorated since the COVID-19 outbreak. However, the few studies published so far have some limitations, such as a cross-sectional design and the omission of important factors for the understanding of perinatal mental health, including governmental restriction measures and healthcare practices implemented at the maternity hospitals. Within the Riseup-PPD COST Action, a study is underway to assess the impact of COVID-19 in perinatal mental health. The primary objectives are to (1) evaluate changes in perinatal mental health outcomes; and (2) determine the risk and protective factors for perinatal mental health during the COVID-19 pandemic. Additionally, we will compare the results between the countries participating in the study. METHODS: This is an international prospective cohort study, with a baseline and three follow-up assessments over a six-month period. It is being carried out in 11 European countries (Albania, Bulgaria, Cyprus, France, Greece, Israel, Malta, Portugal, Spain, Turkey, and the United Kingdom), Argentina, Brazil and Chile. The sample consists of adult pregnant and postpartum women (with infants up to 6 months of age). The assessment includes measures on COVID-19 epidemiology and public health measures (Oxford COVID-19 Government Response Tracker dataset), Coronavirus Perinatal Experiences (COPE questionnaires), psychological distress (BSI-18), depression (EPDS), anxiety (GAD-7) and post-traumatic stress symptoms (PTSD checklist for DSM-V). DISCUSSION: This study will provide important information for understanding the impact of the COVID-19 pandemic on perinatal mental health and well-being, including the identification of potential risk and protective factors by implementing predictive models using machine learning techniques. The findings will help policymakers develop suitable guidelines and prevention strategies for perinatal mental health and contribute to designing tailored mental health interventions. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04595123 .
Authors: Susan J Curry; Alex H Krist; Douglas K Owens; Michael J Barry; Aaron B Caughey; Karina W Davidson; Chyke A Doubeni; John W Epling; David C Grossman; Alex R Kemper; Martha Kubik; C Seth Landefeld; Carol M Mangione; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng; John B Wong Journal: JAMA Date: 2019-02-12 Impact factor: 56.272
Authors: Louise B Andersen; Lisa B Melvaer; Poul Videbech; Ronald F Lamont; Jan S Joergensen Journal: Acta Obstet Gynecol Scand Date: 2012-08-13 Impact factor: 3.636
Authors: Ana Fonseca; Ana Ganho-Ávila; Mijke Lambregtse-van den Berg; Angela Lupattelli; Maria de la Fé Rodriguez-Muñoz; Pedro Ferreira; Sandra Nakić Radoš; Rena Bina Journal: J Affect Disord Date: 2020-05-23 Impact factor: 4.839
Authors: Emily A Holmes; Rory C O'Connor; V Hugh Perry; Irene Tracey; Simon Wessely; Louise Arseneault; Clive Ballard; Helen Christensen; Roxane Cohen Silver; Ian Everall; Tamsin Ford; Ann John; Thomas Kabir; Kate King; Ira Madan; Susan Michie; Andrew K Przybylski; Roz Shafran; Angela Sweeney; Carol M Worthman; Lucy Yardley; Katherine Cowan; Claire Cope; Matthew Hotopf; Ed Bullmore Journal: Lancet Psychiatry Date: 2020-04-15 Impact factor: 27.083
Authors: Kate R Woodworth; Emily O'Malley Olsen; Varsha Neelam; Elizabeth L Lewis; Romeo R Galang; Titilope Oduyebo; Kathryn Aveni; Mahsa M Yazdy; Elizabeth Harvey; Nicole D Longcore; Jerusha Barton; Chris Fussman; Samantha Siebman; Mamie Lush; Paul H Patrick; Umme-Aiman Halai; Miguel Valencia-Prado; Lauren Orkis; Similoluwa Sowunmi; Levi Schlosser; Salma Khuwaja; Jennifer S Read; Aron J Hall; Dana Meaney-Delman; Sascha R Ellington; Suzanne M Gilboa; Van T Tong Journal: MMWR Morb Mortal Wkly Rep Date: 2020-11-06 Impact factor: 17.586
Authors: Grayson B Ashby; Kirsten A Riggan; Lily Huang; Vanessa E Torbenson; Margaret E Long; Myra J Wick; Megan A Allyse; Enid Y Rivera-Chiauzzi Journal: BMC Pregnancy Childbirth Date: 2022-07-04 Impact factor: 3.105
Authors: Ljiljana Jeličić; Mirjana Sovilj; Ivana Bogavac; And Ela Drobnjak; Olga Gouni; Maria Kazmierczak; Miško Subotić Journal: Front Psychol Date: 2021-12-22
Authors: Joana Fernandes; Inês Tavares; Pedro Bem-Haja; Tânia Barros; Mariana L Carrito Journal: Int J Public Health Date: 2022-03-14 Impact factor: 3.380